Developing a novel contrast agent for X-Ray Induced Acoustic CT (XACT) dosimetry, providing real-time in-vivo 3D calibrated radiation dose measurements.
Back to ProjectsX-Ray Induced Acoustic Computed Tomography (XACT) is an emerging imaging modality that combines the principles of X-ray absorption and acoustic wave detection. Our research focuses on developing novel contrast agents for XACT to enable real-time, in-vivo 3D radiation dose measurements during radiation therapy.
Current radiation dosimetry methods have significant limitations: they either provide point measurements, require post-treatment analysis, or cannot be used in-vivo. This makes real-time adaptive radiation therapy challenging, as clinicians cannot directly observe the actual dose distribution within the patient during treatment.
We are developing a groundbreaking system that combines:
Our XACT dosimetry system aims to:
This project is currently in the early experimental phase. We have successfully synthesized and tested several candidate contrast agents in phantom studies and are now preparing for pre-clinical testing.
Dr. David Thomas
Principal Investigator
Mohamed Eldib
Postdoctoral Researcher